What is the Historical Analysis of the Glaucoma Drainage Devices Market Size?
The glaucoma drainage devices market has seen considerable growth due to a variety of factors.
• The market size for glaucoma drainage devices has seen a swift expansion in the past few years. Its growth is projected to increase from $0.81 billion in 2024 to $0.90 billion in 2025, with a compound annual growth rate (CARG) of 10.3%.
The historical growth is primarily driven by factors such as the rising incidence of diabetes, growing elderly population, an increase in the number of hospitals, coupled with a surge in government initiatives and disposable income levels.
What is the Forecasted Market Size and CAGR for the Glaucoma Drainage Devices Market?
The glaucoma drainage devices market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size of glaucoma drainage devices is projected to experience substantial growth. The market is estimated to rise to $1.32 billion by 2029, registering a compound annual growth rate (CAGR) of 10.1%.
Elements contributing to this anticipated expansion during the forecasted span include a greater number of glaucoma cases, an increase in clinical trials, higher healthcare spending, more personalized treatments, and surges in lifestyle diseases. Key trends predicted for this period encompass developments in minimally invasive glaucoma surgery, innovations in microstents and nanotechnology, advancements in biocompatible materials, and an upward trend of integrating glaucoma drainage devices with adjustable and refillable drainage systems.
What Are the Critical Driver Fuelling the Glaucoma Drainage Devices Market's Growth?
A surge in glaucoma cases is projected to spur the expansion of the glaucoma drainage devices market in the future. Glaucoma refers to a collection of eye disorders that impair the optic nerve, typically due to heightened intraocular pressure, which could lead to loss of sight if left untreated. The increased frequency of glaucoma is linked to various factors such as aging, urbanization, and modifications in lifestyle. Glaucoma drainage devices are utilized to control intraocular pressure in refractory glaucoma by helping to drain aqueous humor when standard treatments fall short. For instance, Glaucoma Research Foundation, a leading US-based research organization, stated in March 2022 that nearly 80 million people worldwide were affected by glaucoma as of 2022, with a startling forecast suggesting that approximately half of these individuals are not aware of their condition. In the United States alone, over 3 million people have glaucoma, and a similar number of cases remain undiagnosed. Therefore, the surging frequency of glaucoma is fueling the expansion of the glaucoma drainage devices market.
What Are The Principal Market Segments In The Global Glaucoma Drainage Devices Healthcare Industry?
The glaucoma drainage devices market covered in this report is segmented –
1) By Product Type: Valved Glaucoma Drainage Devices, Non-Valved Glaucoma Drainage Devices
2) By Surgery Type: Conventional Glaucoma Surgery, Minimally Invasive Glaucoma Surgery
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Valved Glaucoma Drainage Devices: Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant, Krupin Implant, Others
2) By Non-Valved Glaucoma Drainage Devices: Molteno Implant, Schocket Implant, Foster Implant, Others
Pre-Book The Glaucoma Drainage Devices Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Glaucoma Drainage Devices
Leading businesses in the glaucoma drainage devices industry are focusing their efforts on developing advanced canal-based glaucoma surgery tools. The aim is to provide minimally intrusive alternatives and cater to the escalating demand for safer, more effective treatments. Devices designed for canal-based glaucoma surgery are implants that primarily target the Schlemm's canal, enhancing the drainage of aqueous humor and thus decreasing intraocular pressure (IOP). This is a crucial step in managing glaucoma as it deals with the primary driver of the condition's advancement. For instance, in March 2023, Australia-based glaucoma devices producer, Nova Eye Medical Limited, got approval for its revolutionary iTrack Advance canaloplasty device. This ground-breaking device is crafted for microcatheterization and viscodilation to diminish intraocular pressure (IOP) in adult patients diagnosed with primary open-angle glaucoma. The iTrack Advance comes with a user-friendly handpiece and upgraded technology to boost surgical efficiency. Its design is suitable for standalone procedures and those conducted alongside cataract surgery.
Who Are the Key Players in the Glaucoma Drainage Devices Market?
Major companies operating in the glaucoma drainage devices market are include:
• AbbVie Inc.
• Alcon Inc.
• Johnson And Johnson Vision Care Inc.
• Santen Pharmaceutical Co. Ltd.
• Glaukos Corporation
• Ocular Therapeutix Inc.
• IRIDEX Corporation
• New World Medical Inc.
• Ivantis Inc.
• iSTAR Medical
• Nova Eye Medical Limited
• Altomed
• Aurolab
• G.surgiwear Limited
• Eagle Vision Inc.
• Advanced Ophthalmic Innovations Pte Ltd.
• Avisi Technologies Inc.
• iVeena Delivery Systems
• Optonol Ltd.
• Rheon-medical
What are the Regional Insights into the Glaucoma Drainage Devices Market?
North America was the largest region in the glaucoma drainage devices market in 2024. The regions covered in the glaucoma drainage devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
